Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial-Reference-Cited by-同舟云学术

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Published:2020-05 Issue:10238 Volume:395 Page:1695-1704
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Hung Ivan Fan-Ngai,Lung Kwok-Cheung,Tso Eugene Yuk-Keung,Liu Raymond,Chung Tom Wai-Hin,Chu Man-Yee,Ng Yuk-Yung,Lo Jenny,Chan Jacky,Tam Anthony Raymond,Shum Hoi-Ping,Chan Veronica,Wu Alan Ka-Lun,Sin Kit-Man,Leung Wai-Shing,Law Wai-Lam,Lung David Christopher,Sin Simon,Yeung Pauline,Yip Cyril Chik-Yan,Zhang Ricky Ruiqi,Fung Agnes Yim-Fong,Yan Erica Yuen-Wing,Leung Kit-Hang,Ip Jonathan Daniel,Chu Allen Wing-Ho,Chan Wan-Mui,Ng Anthony Chin-Ki,Lee Rodney,Fung Kitty,Yeung Alwin,Wu Tak-Chiu,Chan Johnny Wai-Man,Yan Wing-Wah,Chan Wai-Ming,Chan Jasper Fuk-Woo,Lie Albert Kwok-Wai,Tsang Owen Tak-Yin,Cheng Vincent Chi-Chung,Que Tak-Lun,Lau Chak-Sing,Chan Kwok-Hung,To Kelvin Kai-Wang,Yuen Kwok-Yung

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster;Chan;Lancet,2020

2. A pathological report of three COVID-19 cases by minimally invasive autopsies;Yao;Zhonghua Bing Li Xue Za Zhi,2020

3. Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in golden syrian hamster model: implications for disease pathogenesis and tansmissibility;Chan;Clin Infect Dis,2020

4. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds;Chen;J Clin Virol,2004

5. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus;Chan;J Infect,2013

Cited by 1241 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Water resource rejuvenation via AOP based degradation of pharmaceuticals extensively used during COVID-19;Journal of Water Process Engineering;2024-11

2. The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model;Antiviral Research;2024-11

3. Antiviral therapy for COVID-19 virus: A narrative review and bibliometric analysis;The American Journal of Emergency Medicine;2024-11

4. Repurposing of antimycobacterium drugs for COVID-19 treatment by targeting SARS CoV-2 main protease: An in-silico perspective;Gene;2024-09

5. Efficacy of molnupiravir and interferon for the treatment of SARS‐CoV‐2 in golden Syrian hamster;Journal of Medical Virology;2024-08-29